Teri F. Willey

ARCH Development Partners LLC is an Independent Venture Capital firm founded in 2001. The firm is headquartered in Chicago.

NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan.

Spring Mill Venture Partners (Spring Mill) is a venture capital firm founded in 2004 by Ken Green, Jane H. Martin and David O. Mann. The firm is headquartered in Carmel, Indiana.

Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge.

Biosciences Research & Commercialization Center is a Venture Capital firm, a subsidiary of Western Michigan University founded in 2003 by Beverly Cormier. The firm is headquartered in Kalamazoo, US.

Part of The University of Chicago, ARCH Development Corp. is an American company that provides job training and housing development services. The CEO of the company is Duane Gautier.

Cold Spring Harbor Laboratory, Inc. provides research services. It operates educational institutions. The firm offers research in cancer, neurobiology, plant genetics, and bioinformatics. It also offers laboratory workshops to science teachers, students, and other groups across the nation. The company was founded in 1890 and is headquartered in Cold Spring Harbor, NY.

Diagnotes, Inc. provides a communication platform for on-call healthcare providers. It offers communication system for on-call healthcare providers that allow clinicians and patients to connect with on-call providers while simultaneously delivering key patient information from the EHR to the point of care. The company was founded by Dave Wortman, Bharath Bynagari and Todd Saxton in 2010 and is headquartered in Indianapolis, IN.

Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021.